Q: Which nonhormonal treatments are effective for hot flashes? Evidence-based answer: Selective serotonin reuptake inhibitors (SSRIs [fluoxetine, sertraline, paroxetine]) and the selective norepinephrine reuptake inhibitor (SNRI) venlafaxine, as well as clonidine and gabapentin, reduce hot flashes by about 25% (approximately one per day) in women with and without a history of breast cancer. No studies compare medications against each other to determine a single best option (strength of recommendation [SOR]: A, systematic reviews and meta-analyses of randomized controlled trials [RCTs]). In comparison, estrogen reduces the frequency of hot flashes by about 75%, or 2.5 to 3 per day. The phytoestrogens (soy isoflavones, red clover extract, bla...
Objective: Various non-hormonal agents have been used for the treatment of hot flashes in women with...
Purpose: Therapies for breast cancer may induce hot flashes that can affect quality of life. We unde...
Hot flushes/flashes (HFs) or other vasomotor symptoms affect between 45 and 97% of women during meno...
Context Concern regarding the adverse effects of estrogen and other hormones for treating menopausal...
Patient-centered decision making about hot flash treatments often incorporates a balance of efficacy...
BACKGROUND Hot flushes are common in women with a history of breast cancer. Hormonal therapies are k...
ContextConcerns regarding the risks associated with estrogen and progesterone to manage menopausal s...
OBJECTIVE: The objective of this selective Evidence Based Medicine (EBM) review is to determine whet...
Regular exercise may reduce vasomotor symptoms of menopause (strength of recommendation [SOR]: C--si...
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer, this may incr...
Background Hot flashes can be troublesome, especially when hormonal therapy is contraindicated. Prel...
Abstract Background: Homeopathic medicines have a place among the non-hormonal therapies for the tre...
IntroductionVasomotor symptoms, or hot flashes, are among the most common complaints for menopausal ...
Abstract Background Breast and prostate cancers are t...
Introduction: Menopausal complaints are a critical aspect of women’s lives. In particular vasomotor ...
Objective: Various non-hormonal agents have been used for the treatment of hot flashes in women with...
Purpose: Therapies for breast cancer may induce hot flashes that can affect quality of life. We unde...
Hot flushes/flashes (HFs) or other vasomotor symptoms affect between 45 and 97% of women during meno...
Context Concern regarding the adverse effects of estrogen and other hormones for treating menopausal...
Patient-centered decision making about hot flash treatments often incorporates a balance of efficacy...
BACKGROUND Hot flushes are common in women with a history of breast cancer. Hormonal therapies are k...
ContextConcerns regarding the risks associated with estrogen and progesterone to manage menopausal s...
OBJECTIVE: The objective of this selective Evidence Based Medicine (EBM) review is to determine whet...
Regular exercise may reduce vasomotor symptoms of menopause (strength of recommendation [SOR]: C--si...
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer, this may incr...
Background Hot flashes can be troublesome, especially when hormonal therapy is contraindicated. Prel...
Abstract Background: Homeopathic medicines have a place among the non-hormonal therapies for the tre...
IntroductionVasomotor symptoms, or hot flashes, are among the most common complaints for menopausal ...
Abstract Background Breast and prostate cancers are t...
Introduction: Menopausal complaints are a critical aspect of women’s lives. In particular vasomotor ...
Objective: Various non-hormonal agents have been used for the treatment of hot flashes in women with...
Purpose: Therapies for breast cancer may induce hot flashes that can affect quality of life. We unde...
Hot flushes/flashes (HFs) or other vasomotor symptoms affect between 45 and 97% of women during meno...